Therefore, the modulation of the levels of PPA and GSK3β activity by PS128 supplementation may play a role in preventing cognitive dysfunction and promoting memory consolidation in the 3 × Tg-AD mice treated with icv-STZ, as shown in Fig. 8. This evidence concerns the gene GSK3B and Alzheimer disease.